HDAC9/p300/F-actin immunoexpression and migration analysis for malignant melanoma stem cell

Area of Science:

• Oncology
• Epigenetics
• Cell Biology

Background:

• Melanoma is an aggressive cancer with poor prognosis, especially in the metastatic phase.
• Epigenetic mechanisms are crucial for cancer stem cells (CSCs) activity and malignant melanoma (MM) progression.
• Targeting epigenetic modifications presents a promising therapeutic strategy for melanoma.

Purpose of the Study:

• To compare the expression of p300, HDAC9, and F-actin proteins in melanoma CSCs (CD133+), non-CSCs (CD133-), and the CHL-1 cell line.
• To analyze the impact of these proteins on cell migration and division rates.
• To elucidate the molecular basis of MM initiation and progression.

Main Methods:

• Protein level comparison of p300, HDAC9, and F-actin in CD133+ melanoma CSCs, CD133- non-CSCs, and CHL-1 cells.
• Assessment of cell migration and division rates over time.
• Quantitative analysis of protein expression changes at 4 and 6 hours of incubation.

Main Results:

• p300 protein levels were similar in CHL-1 and CD133+ cells at 4 and 6 hours, while CD133- cells showed increased expression.
• HDAC9 protein intensity decreased in CHL-1, increased in CD133- cells, and remained stable in CD133+ cells over time.
• F-actin expression increased in all cell groups, with the most significant increase observed in CHL-1 cells.

Conclusions:

• The study provides insights into the differential expression of key proteins in melanoma CSCs and non-CSCs.
• Findings contribute to understanding the molecular mechanisms driving melanoma progression and metastasis.
• This research may inform future therapeutic strategies targeting epigenetic modifications in metastatic melanoma.